165 related articles for article (PubMed ID: 10419751)
1. Following metastatic placental site trophoblastic tumor with urine beta-core fragment.
Rinne K; Shahabi S; Cole L
Gynecol Oncol; 1999 Aug; 74(2):302-3. PubMed ID: 10419751
[TBL] [Abstract][Full Text] [Related]
2. Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study.
Schutter EM; Mijatovic V; Kok A; Van Kamp GJ; Verstraeten R; Verheijen RH
Anticancer Res; 1999; 19(6C):5551-7. PubMed ID: 10697615
[TBL] [Abstract][Full Text] [Related]
3. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
[TBL] [Abstract][Full Text] [Related]
4. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
Kitajima T; Mochizuki M; Nishimura R
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):297-303. PubMed ID: 1710641
[TBL] [Abstract][Full Text] [Related]
5. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
O'Connor JF; Schlatterer JP; Birken S; Krichevsky A; Armstrong EG; McMahon D; Canfield RE
Cancer Res; 1988 Mar; 48(5):1361-6. PubMed ID: 2449279
[TBL] [Abstract][Full Text] [Related]
6. UGP in urogenital disorders: Egyptian experience.
el-Ahmady O; Halim AB; Gad M; Walker R
Anticancer Res; 1996; 16(4B):2301-8. PubMed ID: 8694560
[TBL] [Abstract][Full Text] [Related]
7. [Development of highly sensitive enzyme immunoassay to measure urinary beta-core fragment in patients with gynecological cancer].
Nishimura R; Kobayashi K; Katsuno M; Kobayashi T
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):143-8. PubMed ID: 1690253
[TBL] [Abstract][Full Text] [Related]
8. Urinary gonadotropin peptide (UGP) as a marker of gynecologic malignancies.
Walker R; Crebbin V; Stern J; Scudder S; Schwartz P
Anticancer Res; 1994; 14(5A):1703-9. PubMed ID: 7847804
[TBL] [Abstract][Full Text] [Related]
9. The correlation of beta-subunit human chorionic gonadotropin level in the serum and first morning urine of patients with gestational trophoblastic disease.
Benjapibal M; Wataganara T; Senawong S; Boriboonhirunsarn D; Suphanit I
J Med Assoc Thai; 2001 Jul; 84(7):1000-5. PubMed ID: 11759958
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of urinary beta-core fragment of hCG as a tumor marker of cervical cancer].
Kinugasa M; Nishimura R; Hasegawa K; Okamura M; Kimura A; Ohtsu F; Takeuchi K
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):188-94. PubMed ID: 1545171
[TBL] [Abstract][Full Text] [Related]
11. Urinary concentrations of beta core fragment of hCG throughout pregnancy.
de Medeiros SF; Amato F; Matthews CD; Norman RJ
Obstet Gynecol; 1992 Aug; 80(2):223-8. PubMed ID: 1378955
[TBL] [Abstract][Full Text] [Related]
12. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report.
Cole LA; Tanaka A; Kim GS; Park SY; Koh MW; Schwartz PE; Chambers JT; Nam JH
Gynecol Oncol; 1996 Feb; 60(2):264-70. PubMed ID: 8631549
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of urinary beta core fragment in premenopausal women with carcinoma of the cervix.
Carter PG; Iles RK; Neven P; Ind TE; Shepherd JH; Chard T
Gynecol Oncol; 1994 Nov; 55(2):271-6. PubMed ID: 7525427
[TBL] [Abstract][Full Text] [Related]
14. Blood test for placental site trophoblastic tumor and nontrophoblastic malignancy for evaluating patients with low positive human chorionic gonadotropin results.
Cole LA; Khanlian SA; Muller CY
J Reprod Med; 2008 Jul; 53(7):457-64. PubMed ID: 18720919
[TBL] [Abstract][Full Text] [Related]
15. The molar vesicle fluid contains the beta-core fragment of human chorionic gonadotropin.
Khan S; Katabuchi H; Araki M; Ohba T; Koizumi T; Okamura H; Nishimura R
Placenta; 2000 Jan; 21(1):79-87. PubMed ID: 10692255
[TBL] [Abstract][Full Text] [Related]
16. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
[TBL] [Abstract][Full Text] [Related]
17. [Human chorionic gonadotropin beta-core fragment (hCG beta-cf)].
Okamoto T
Nihon Rinsho; 1999 Dec; 57 Suppl():586-8. PubMed ID: 10778198
[No Abstract] [Full Text] [Related]
18. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
Cole LA; Sutton JM
J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
[TBL] [Abstract][Full Text] [Related]
19. Serum human chorionic gonadotropin regression pattern in persistent trophoblastic disease during chemotherapy.
Lertkhachonsuk R; Limpongsanurak S
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S352-9. PubMed ID: 11529357
[TBL] [Abstract][Full Text] [Related]
20. [Fragments of human chorionic gonadotropin (hCG): diagnosis of pregnancy and tumors].
Lechner O; Dirnhofer S; Gerth R; Merz WE; Wick G; Berger P
Wien Klin Wochenschr; 1995; 107(1):15-9. PubMed ID: 7871785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
